Journal article

Risperidone Versus Placebo for Schizophrenia

Ranganath D Rattehalli, Mahesh B Jayaram, Michael Smith

The Cochrane Library | OXFORD UNIV PRESS | Published : 2010

DOI: 10.1093/schbul/sbq030

University of Melbourne Researchers

Grants

Funding Acknowledgements

We wish to thank Clive Adams, Beth York and Sam Roberts from the Cochrane Schizophrenia Group for their help and support with this review.Internal sourcesLeeds Partnerships NHS Foundation Trust, UKExternal sourcesUniversity of Nottingham, UK.

Citation metrics

3Web of Science
14Web of Science
4Scopus

Keywords

Randomized Clinical Trials
Brief Psychiatric Rating Scale
Long-Acting Risperidone
Medicine, General & Internal
Cognitive Impairment
Conventional Antipsychotic-Drugs
Antipsychotic Agents
Science & Technology
Administration, Oral
Negative Symptoms
Risperidone
Systematic Review
Donepezil Adjunctive Treatment
Psychiatry
Mental Status Schedule
Humans
Treatment Outcome
Meta-Analysis
Schizophrenia
Schizophrenic Psychology
Severe Tardive-Dyskinesia
Vitamin-E Treatment
Randomized Controlled-Trials
Psychotic Disorders
Term Treatment
Randomized Controlled Trials As Topic
Double-Blind
Life Sciences & Biomedicine
General & Internal Medicine